Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.7.2024Viatris Limited (VIM)39932Quetiapine Viatris 200 mg (tbl flm 60x200 mg (blis.PVC/PVDC/Al))23.7.2024O
 23.7.2024Takeda GmbH (TKD-3)6652ACONTROLOC 40 mg (tbl ent 100x40 mg (blis.Al/Al so spevn.kartón.obalom))23.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))15.7.2024R
 23.7.2024MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))15.7.2024R
 23.7.2024MEDOCHEMIE Ltd. (MOE)96084MEDOFLUCON 150 mg (cps dur 1x150 mg (blis.PVC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)67569MABRON 50 mg (cps dur 20x50 mg (blis.Al/PVC))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)8708DBROXIVAN 6 mg/ml perorálny roztok (sol por 1x200 ml/1200 mg (fľ.skl.hnedá+plast.odmer.))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)67570MABRON 50 mg (cps dur 30x50 mg (blis.Al/PVC))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)33199MEDOFLUCON 50 mg (cps dur 100x50 mg (blis.PVC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)93335MABRON RETARD 150 (tbl plg 30x150 mg (blis.Al/PVC))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)0907CSiranalen 150 mg tvrdé kapsuly (cps dur 84x150 mg (blis.PVC/PVDC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)0920CSiranalen 300 mg tvrdé kapsuly (cps dur 56x300 mg (blis.PVC/PVDC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)67030MEDOFLUCON 50 mg (cps dur 7x50 mg (blis.PVC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)67031MEDOFLUCON 150 mg (cps dur 10x150 mg (blis.PVC/Al))15.7.2024R
 23.7.2024MEDOCHEMIE Ltd. (MOE)0326DSOFENTIL 50 mikrogramov/ml injekčný/infúzny roztok (sol ijf 5x5 ml (amp.skl.))15.7.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)